ADVFN US – Market Content Editor
-
Stronger Than Expected Jobs Data Leads To Record Highs On Wall Street
After moving mostly higher over the course of Wednesday’s session, stocks saw continued strength during trading on Thursday. With the continued advance, the Nasdaq and the S&P 500 once again reached new record closing highs. The major averages moved roughly sideways after an early upward move, hovering firmly in positive territory. The Nasdaq jumped 207.97…
-
CoreWeave Stock Rises as It Launches NVIDIA’s Powerful New GB300 NVL72 AI Platform
Shares of CoreWeave Inc. (NASDAQ:CORE) gained 3.2% on Thursday after the company unveiled its role as the first cloud provider to roll out NVIDIA’s (NASDAQ:NVDA) groundbreaking GB300 NVL72 AI system—marking a major leap in generative AI infrastructure. The GB300 NVL72 platform represents a significant step forward in AI processing, offering up to 10 times faster…
-
CrowdStrike Reaches Record High Amid Surging Demand for Cybersecurity
CrowdStrike Holdings Inc. (NASDAQ:CRWD) soared to a new all-time high of $516.83, underscoring investor enthusiasm and the company’s continued strength in the cybersecurity space. The milestone pushes its market valuation to $128.5 billion and reflects a 33.12% gain over the past 12 months. The rally highlights CrowdStrike’s sustained growth as organizations increasingly invest in advanced…
-
ASML Dips After Samsung Pushes Back Texas Chip Plant Timeline
Shares of ASML Holding NV (NASDAQ:ASML) edged down 0.9% after reports emerged that Samsung Electronics is delaying progress on its U.S.-based semiconductor factory, casting uncertainty over future equipment orders. According to Nikkei Asia, the South Korean tech giant is slowing the installation of chipmaking machinery at its Texas facility amid difficulties securing a sufficient customer…
-
Summit Therapeutics Shares Climb Amid Rumored $15B Deal Talks with AstraZeneca
Shares of Summit Therapeutics (NASDAQ:SMMT) jumped 5% on Thursday following reports that the company is in advanced negotiations with AstraZeneca (NASDAQ:AZN) over a potential multi-billion-dollar licensing agreement. Meanwhile, AstraZeneca’s stock dipped 2% amid investor reactions to the potential outlay. Citing sources familiar with the matter, Bloomberg reported that AstraZeneca is eyeing Summit’s experimental lung cancer…
-
Bitcoin Surges Past $110K as Trade Optimism Spurs Risk Appetite
Bitcoin (COIN:BTCUSD) climbed higher on Thursday, building on gains from the previous day amid positive developments in U.S. trade relations. However, traders remained cautious ahead of a series of important U.S. economic reports scheduled for later in the day. The largest cryptocurrency appeared to break out of its recent $103,000 to $108,000 trading band on…
-
Charles Schwab Shares Reach 52-Week Peak at $91.82
Charles Schwab Corporation (NYSE:SCHW) hit a fresh 52-week high, with its stock climbing to $91.82. This marks a notable gain for the financial services leader, whose share price has increased nearly 25% over the past year. The company’s market cap now stands at approximately $166 billion, fueled by a strong year-to-date performance of 24.22%, driven…
-
U.S. Stocks Climb on Strong Jobs Data; Markets Eye Trade Deals and Tax Bill
U.S. stocks edged higher Thursday following a stronger-than-expected jobs report that underscored the labor market’s resilience, bolstering investor optimism around potential trade deals and fiscal policy progress. As of 09:32 ET the Dow Jones Industrial Average was up 80 points (0.2%), the S&P 500 gained 24 points (0.4%), and the NASDAQ Composite rose 120 points…
-
Ascent Solar Shares Surge Following Launch of NASA Partnership
Ascent Solar Technologies Inc. (NASDAQ:ASTI) saw its stock jump 18% after announcing the official start of its collaboration with NASA’s Marshall Space Flight Center (MSFC). Backed by support from NASA’s Glenn Research Center, this partnership aims to advance spacecraft technology capable of receiving beamed power through Ascent’s CIGS thin-film photovoltaic modules. This innovation enables energy…
-
Bank of NY Mellon Stock Reaches Record Peak at $92.64
Shares of Bank of NY Mellon Corporation (NYSE:BK) have surged to a new all-time high of $92.64, reflecting a strong 56.2% gain over the past twelve months. This impressive rise signals solid investor confidence and underscores the company’s healthy financial standing, bolstered by 14 consecutive years of dividend growth and a reliable dividend yield of…